Aquestive Therapeutics, Inc. AQST Tax on Share Settlement
Tax on Share Settlement at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s tax on share settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s tax on share settlement?
- Aquestive Therapeutics, Inc. (AQST) reported tax on share settlement of $329K in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s tax on share settlement changed year-over-year?
- Aquestive Therapeutics, Inc.'s tax on share settlement decreased by 53.2% year-over-year, from $703K to $329K.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s tax on share settlement?
- Over 3 years (2021 to 2025), Aquestive Therapeutics, Inc.'s tax on share settlement has grown at a 286.8% compound annual growth rate (CAGR), from $14K to $810K.
- What does tax on share settlement mean?
- Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.